Supported by

LAA (Left Atrial Appendage) closure

Find all the latest content on left atrial appendage (LAA) published on this website.

Today, with an aging population, atrial fibrillation is more common and carries with it an increased risk of embolic cerebrovascular accidents. Anticoagulation strategies alone are not sufficient, and as a large proportion of the thrombus involved in these cerebrovascular accidents are seen to arise in the left atrial appendage (LAA), its closure, either surgically or by percutaneous methods, could reduce risk. Learn more about imaging, tools, devices and techniques as well as adjunctive pharmacotherapy, vascular access and bleeding here…

Filtered By
LAA closure

78 results

Printed MDCT 3D models for prediction of left atrial appendage (LAA) occluder device size: a feasibility study

Salvatore Brugaletta


Salvatore Brugaletta

EWOLUTION 1 year follow up results

The prospective study confirms the safety and efficacy of the WATCHMAN Left atrial appendage closure device in stroke risk reduction in patients with high risk of stroke, bleeding and multiple co-morbidities.

The AMPLATZER™ Amulet™ – facing the challenge of left atrial appendage occlusion

Over the last decade left atrial appendage occlusion has been a topic of intense clinical research

PFO closure reduces recurrent strokes – a therapeutic promise is finally kept

22 May 2017

In patients with a patent foramen ovale (PFO) and cryptogenic stroke, percutaneous closure of the PFO has long been postulated to reduce the rate of recurrent strokes. However, up until now, trial data has failed to convincingly deliver a message of benefit for such an approach. Although the wait has been long, two recently reported trials finally seem to deliver on the therapeutic promise of PFO closure.

EuroPCR 2017 Highlights: Interventions for Stroke

20 May 2017 - From EUROPCR 2017

Interventional treatment of stroke is the future! M. Roffi and Ö. Göktekin along with L. N. Hopkins, neurosurgeon, explain how interventional cardiologists can respond to this challenge. Robust data supporting mechanical treatment of acute stroke increases daily. Until recently we believed intervention worked only within a 6 hour window, but now, the newly released DAWN trial shows that patient selection, IV r-tPA + clot retrieval can have a positive benefit for up to 24 hours after a stroke. An army of interventionalists is needed to treat the millions of eligible patients!

LAA closure

19 May 2017 – From EuroPCR 2017

Consult this session on LAA closure, that includes a LIVE demonstration from the Cardiovascular Centre, OLV Aalst - Aalst, Belgium.

Complex LAA closure interventions

18 May 2017 – From EuroPCR 2017

Moderated posters - session 3

18 May 2017 – From EuroPCR 2017

How to start a left atrial appendage programme


With 25% of all individuals over the age of 45 being at risk of developing atrial fibrillation you might be interested as a young practitioner in starting your own LAAC programme…but where do you begin? Join D. Hildick-Smith, D. Holmes and Eric Brochet as they lead us through the various essential steps and clinical knowledge needed to face this still unmet need. In a track designed “By and For” Young specialists, they explore where you could find your proctors, how you can choose optimal candidates for this intervention and look at currently available data on such subjects as pharmacotherapy… Learn more by watching here.

An image is worth 1,000 words

18 May 2017 – From EuroPCR 2017